Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

80 та иш

Иш: Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery

  1. Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer

    Corrine Ying Xuan Chua, Priya Jain, Antonia Susnjar +10

    Мақола20184 иқтибос
    ABI

  2. Leveraging nanochannels for universal, zero-order drug delivery in vivo

    Silvia Ferrati, Daniel H. Fine, Junping You +16

    Мақола20133 иқтибос
    ABI

  3. A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery

    Daniel H. Fine, Alessandro Grattoni, Sharath Hosali +11

    Мақола20103 иқтибос
    ABI

  4. Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale

    Giacomo Bruno, Nicola Di Trani, R. Lyle Hood +10

    Мақола20183 иқтибос
    ABI

  5. Finite-Size Charged Species Diffusion and pH Change in Nanochannels

    Nicola Di Trani, Alberto Pimpinelli, Alessandro Grattoni

    Мақола20203 иқтибос
    ABI

  6. Dielectric breakdown I: A review of oxide breakdown

    J.F. Verweij, J.H. Klootwijk

    Шарҳ мақола19962 иқтибос
    ABI

  7. In situ imaging of the conducting filament in a silicon oxide resistive switch

    Jun Yao, Lin Zhong, Douglas Natelson +1

    Мақола20122 иқтибос
    ABI

  8. Robotic UV-Vis apparatus for long-term characterization of drug release from nanochannels

    Thomas Geninatti, Enoch W. Small, Alessandro Grattoni

    Мақола20142 иқтибос
    ABI

  9. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

    Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng +3

    Мақола20022 иқтибос
    ABI

  10. Adherence to Long‐Term Therapies: Evidence for Action

    Patricia V. Burkhart, E Sabaté

    Мақола20032 иқтибос
    ABI

  11. Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis

    Corrine Ying Xuan Chua, Priya Jain, Andrea Ballerini +17

    Мақола20182 иқтибос
    ABI

  12. Gas Flow at the Ultra-nanoscale: Universal Predictive Model and Validation in Nanochannels of Ångstrom-Level Resolution

    Giovanni Scorrano, Giacomo Bruno, Nicola Di Trani +3

    Мақола20182 иқтибос
    ABI

  13. 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis

    Fernanda P. Pons‐Faudoa, Antons Sizovs, Nicola Di Trani +10

    Мақола20192 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI